Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
Yulan Xiong, Stewart Neifert, Senthilkumar S. Karuppagounder, et al.
eNeuro (2017) Vol. 4, Iss. 2, pp. ENEURO.0004-17.2017
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
Panchanan Maiti, Jayeeta Manna, Gary Dunbar
Translational Neurodegeneration (2017) Vol. 6, Iss. 1
Open Access | Times Cited: 455
Modeling Parkinson’s Disease in Drosophila: What Have We Learned for Dominant Traits?
Yulan Xiong, Jianzhong Yu
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 87
Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice
Yulan Xiong, Stewart Neifert, Senthilkumar S. Karuppagounder, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 7, pp. 1635-1640
Open Access | Times Cited: 86
Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner
Bojan Shutinoski, Mansoureh Hakimi, Irene E. Harmsen, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 511
Closed Access | Times Cited: 83
PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
Wen Li, YuHong Fu, Glenda M. Halliday, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 70
Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease
Shahzad S. Khan, Ebsy Jaimon, Yu‐En Lin, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 32
Open Access | Times Cited: 11
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
Darren M. O’Hara, Grishma Pawar, Suneil K. Kalia, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 63
The unlikely partnership between LRRK2 and α‐synuclein in Parkinson's disease
Noémie Cresto, Gardier Camille, Francesco Gubinelli, et al.
European Journal of Neuroscience (2018) Vol. 49, Iss. 3, pp. 339-363
Open Access | Times Cited: 40
Behavioral Changes in Mice Lacking Interleukin-33
Eisuke Dohi, Eric Y. Choi, Indigo V.L. Rose, et al.
eNeuro (2017) Vol. 4, Iss. 6, pp. ENEURO.0147-17.2017
Open Access | Times Cited: 34
Genetically engineered animal models of Parkinson's disease: From worm to rodent
Ludivine S. Breger, Marie‐Thérèse Armentero
European Journal of Neuroscience (2018) Vol. 49, Iss. 4, pp. 533-560
Closed Access | Times Cited: 33
Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
Li Zou, Ye Tian, Zhentao Zhang
Frontiers in Integrative Neuroscience (2021) Vol. 15
Open Access | Times Cited: 25
Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson’s disease
Sheila K. Pirooznia, Hu Wang, Nikhil Panicker, et al.
Science Advances (2022) Vol. 8, Iss. 13
Open Access | Times Cited: 18
Viral mediated α-synuclein overexpression results in greater transgene levels and α-synuclein overload in mice bearing kinase dead mutation of LRRK2
Federica Albanese, Chiara Domenicale, Daniela Mercatelli, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE‐mediated mRNA decay in Parkinson's disease
Qinfang Liu, Dong Zhu, Naren Li, et al.
The EMBO Journal (2023) Vol. 42, Iss. 15
Closed Access | Times Cited: 9
Protein Translation in the Pathogenesis of Parkinson’s Disease
Daniyal Ashraf, Mohammed Repon Khan, Ted M. Dawson, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2393-2393
Open Access | Times Cited: 3
High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification
Aurore Vuidel, Loïc Cousin, Beatrice Weykopf, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 10, pp. 2349-2364
Open Access | Times Cited: 14
LRRK2 and Proteostasis in Parkinson’s Disease
María Dolores Pérez‐Carrión, Inmaculada Posadas, Javier Solera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6808-6808
Open Access | Times Cited: 13
The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo
Noémie Cresto, Marie‐Claude Gaillard, Camille Gardier, et al.
Neurobiology of Disease (2019) Vol. 134, pp. 104614-104614
Open Access | Times Cited: 18
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
Andrea Mancini, Petra Mazzocchetti, Miriam Sciaccaluga, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 18
LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal Models
Dylan J. Dues, Darren J. Moore
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 17
Synaptic proteostasis in Parkinson's disease
Eliana Nachman, Patrik Verstreken
Current Opinion in Neurobiology (2021) Vol. 72, pp. 72-79
Open Access | Times Cited: 14
Modeling Parkinson’s disease in LRRK2 rodents
Chiara Domenicale, Stefano Magnabosco, Michele Morari
Neuronal Signaling (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 5
Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains
Jungwoo Wren Kim, Xiling Yin, Ian Martin, et al.
eNeuro (2021) Vol. 8, Iss. 6, pp. ENEURO.0310-21.2021
Open Access | Times Cited: 11
The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo
Noémie Cresto, Camille Gardier, Marie‐Claude Gaillard, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6760-6760
Open Access | Times Cited: 10
Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells
Liesel Goveas, Eugénie Mutez, Marie‐Christine Chartier‐Harlin, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 981-981
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top